An electrical biosensor for the detection of circulating tumor cells

被引:67
作者
Chung, Yao-Kuang [1 ]
Reboud, Julien [1 ]
Lee, Kok Chuan [1 ]
Lim, Hui Min [1 ]
Lim, Pei Yi [1 ]
Wang, Karen Yanping [1 ]
Tang, Kum Cheong [1 ]
Ji, HongMiao [1 ]
Chen, Yu [1 ]
机构
[1] ASTAR, Inst Microelect, Singapore 117685, Singapore
关键词
Circulating tumor cells (CTC); Immunomagnetic; Microelectrode array (MEA); METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; QUANTIFICATION; PROGRESSION; TECHNOLOGY; SURVIVAL; THERAPY; CAPTURE;
D O I
10.1016/j.bios.2010.10.048
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In this report, we demonstrate a semi-integrated electrical biosensor for the detection of rare circulating tumor cells (CTCs) in blood. The sample was first enriched through a combination of immunomagnetic isolation and size filtration. The integration of both methods provided a high enrichment performance with a recovery rate above 70%, even for very low numbers of cancer cells present in the original sample (10 spiked MCF7 cells in 0.5 mL of blood). In the same system, the sample was then transferred to a microchip for further magnetic concentration, followed by immunochemical trapping and electronic detection by impedance spectroscopy. Three levels of spiked CTC number (30 +/- 2, 124 +/- 29, 273 +/- 23) in 10 mu L of filtered blood sample were distinguished by monitoring the impedance change of the microelectrode array (MEA). The integration of different functions in a single system provided a methodology to process milliliter-sized blood samples at the macroscale and interface with the microdimensions of a highly sensitive electronic detector. The results showed that the whole system was able to detect different levels of spiked cancer cells without the use of time- and cost-intensive fluorescence labeling and image analysis. This has the potential to provide clinicians with a standalone system to monitor changes in CTC numbers throughout therapy conveniently and frequently for efficient cancer treatments. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2520 / 2526
页数:7
相关论文
共 23 条
[1]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[2]  
Baker MK, 2003, CLIN CANCER RES, V9, P4865
[3]  
Benez A, 1999, J CLIN LAB ANAL, V13, P229, DOI 10.1002/(SICI)1098-2825(1999)13:5<229::AID-JCLA7>3.3.CO
[4]  
2-P
[5]   EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges [J].
Chaudry, M. A. ;
Sales, K. ;
Ruf, P. ;
Lindhofer, H. ;
Winslet, M. C. .
BRITISH JOURNAL OF CANCER, 2007, 96 (07) :1013-1019
[6]   Real-time monitoring approach: Assessment of effects of antibodies on the adhesion of NCI-H460 cancer cells to the extracellular matrix [J].
Chen, Yu ;
Zhang, Juntao ;
Wang, Yanping ;
Zhang, Li ;
Julien, Reboud ;
Tang, Kumcheong ;
Balasubramanian, Narayanan .
BIOSENSORS & BIOELECTRONICS, 2008, 23 (09) :1390-1396
[7]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[8]   Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer [J].
Fan, Tina ;
Zhao, Qiang ;
Chen, John J. ;
Chen, Wen-Tien ;
Pearl, Michael L. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :185-191
[9]  
Fehm T, 2002, CLIN CANCER RES, V8, P2073
[10]   Isolation of rare cells from cell mixtures by dielectrophoresis [J].
Gascoyne, Peter R. C. ;
Noshari, Jamileh ;
Anderson, Thomas J. ;
Becker, Frederick F. .
ELECTROPHORESIS, 2009, 30 (08) :1388-1398